Stéphane Culine

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.

Philippe Rougier, R. Bugat, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 1997 · 429 citations

Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer: ELCAPA Study

Philippe Caillet, Florence Canouï‐Poitrine, Johanna Vouriot et al. · Journal of Clinical Oncology · 2011 · 417 citations · Full text

Viable Malignant Cells After Primary Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors: Prognostic Factors and Role of Postsurgery Chemotherapy—Results From an International Study Group

Karim Fizazi, Sergei Tjulandin, Roberto Salvioni et al. · Journal of Clinical Oncology · 2001 · 279 citations

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

S. Krege, J. Beyer, Rainer Souchon et al. · European Urology · 2008 · 252 citations

Germ Cell Cancer, Genitourinary Cancer, Medicine +9

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses

Christian Pfister, Gwénaëlle Gravis, Aude Fléchon et al. · European Urology · 2020 · 238 citations · Full text

Urology, Genitourinary Cancer, Chemotherapy Toxicity +7